| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Niedersächsisches Institut für Peptid-Forschung (S.M., K.A., W.-G.F.), 30625 Hannover; and Institut für Pharmakologie und Toxikologie (M.K.), Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
Address all correspondence and requests for reprints to: Michaela Kuhn, Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität Münster, Domagkstrasse 12, 48149 Münster, Germany. E-mail: mkuhn{at}uni-muenster.de
Guanylin, an activator of the guanylyl cyclase C receptor in the apical membrane of intestinal epithelium, modulates intestinal fluid and electrolyte transport. The bioactive 15-amino acid peptide originally isolated from rat intestine represents the C-terminal part of a longer, 115-residue prepropeptide. The aim of the present study was to characterize the direction and molecular form in which guanylin is secreted from the colonic mucosa, as well as the mechanisms that trigger its secretion. Isolated rat colonic mucosa was mounted in Ussing chambers, allowing the separate determination of apical and basolateral release. After HPLC purification, two different molecular forms of guanylin were identified in the apical incubation media by combining a bioassay for guanylyl cyclase C activation, a specific guanylin enzyme-linked immunosorbent assay and mass spectrometry, as well as sequence analysis: a bioactive form coeluting with synthetic 15-residue guanylin and the 94-residue propeptide, guanylin-22115. The basal concentration of proguanylin at the apical side of epithelia was about 15-fold higher, compared with that of the small, bioactive peptide. In the basolateral incubation media, no proguanylin and only very low amounts of bioactive guanylin were detected. Incubation with carbachol led to a significant increase of about 7-fold in the release of proguanylin to both sides of the isolated epithelia. On the apical side, a concomitant increase of the small, bioactive peptide was observed; whereas, on the basolateral side, its concentration remained unchanged. Vasoactive intestinal peptide or the NO-donor S-nitroso-N-acetylpenicillamine did not affect guanylin secretion. Our results suggest that, in the intestine, guanylin is secreted mainly to the luminal side of the epithelium. The peptide is released as a 94-residue propeptide, which is then processed to a smaller, bioactive form (luminocrine secretion). Carbachol stimulates the release of proguanylin to both sides of the intestinal mucosa, but a parallel increase in the bioactive C-terminal derivative only occurs on the apical side. In vivo, the basolateral release could be a source of circulating proguanylin, which might be processed proteolytically to the active peptide in distant target tissues (endocrine secretion).
This article has been cited by other articles:
![]() |
J. A. Rudolph, J. A. Hawkins, and M. B. Cohen Proguanylin secretion and the role of negative-feedback inhibition in a villous epithelial cell line Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G695 - G702. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kulaksiz, E. Rehberg, W. Stremmel, and Y. Cetin Guanylin and Functional Coupling Proteins in the Human Salivary Glands and Gland Tumors : Expression, Cellular Localization, and Target Membrane Domains Am. J. Pathol., August 1, 2002; 161(2): 655 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kulaksiz, A. Schmid, M. Honscheid, A. Ramaswamy, and Y. Cetin Clara cell impact in air-side activation of CFTR in small pulmonary airways PNAS, May 14, 2002; 99(10): 6796 - 6801. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kunzelmann and M. Mall Electrolyte Transport in the Mammalian Colon: Mechanisms and Implications for Disease Physiol Rev, January 1, 2002; 82(1): 245 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Potthast, E. Ehler, L. A. Scheving, A. Sindic, E. Schlatter, and M. Kuhn High Salt Intake Increases Uroguanylin Expression in Mouse Kidney Endocrinology, July 1, 2001; 142(7): 3087 - 3097. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qian, S. Prabhakar, A. Nandi, S. S. Visweswariah, and M. F. Goy Expression of GC-C, a Receptor-Guanylate Cyclase, and Its Endogenous Ligands Uroguanylin and Guanylin along the Rostrocaudal Axis of the Intestine Endocrinology, September 1, 2000; 141(9): 3210 - 3224. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moro, F. Levenez, E. Nemoz-Gaillard, S. Pellissier, P. Plaisancie, and J. C. Cuber Release of Guanylin Immunoreactivity from the Isolated Vascularly Perfused Rat Colon Endocrinology, July 1, 2000; 141(7): 2594 - 2599. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |